Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Levodopa”

453 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 453 results

Not applicableUnknownNCT04173832
What this trial is testing

Clinical Study on Treatment of L-DOPA-Induced Dyskinesia With Tianqi Pingchan Granule Combined With Amantadine

Who this might be right for
L-DOPA-Induced Dyskinesia
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 100
Post-approval studies (Phase 4)Study completedNCT03111485
What this trial is testing

Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease

Who this might be right for
Parkinson's DiseaseObstructive Sleep Apnea
McGill University Health Centre/Research Institute of the McGill University Health Centre 36
Early research (Phase 1)Study completedNCT03374917
What this trial is testing

A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment

Who this might be right for
Parkinson's Disease (PD)
AbbVie 20
Post-approval studies (Phase 4)Study completedNCT01049984
What this trial is testing

Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease

Who this might be right for
Parkinson's Disease
Teva Neuroscience, Inc. 328
Testing effectiveness (Phase 2)Study completedNCT01474421
What this trial is testing

Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease

Who this might be right for
DyskinesiasDrug-induced
Novartis Pharmaceuticals 71
Large-scale testing (Phase 3)Study completedNCT03391882
What this trial is testing

An Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)

Who this might be right for
Motor OFF Episodes Associated With Parkinson's Disease
Sumitomo Pharma America, Inc. 113
Testing effectiveness (Phase 2)Study completedNCT00314288
What this trial is testing

Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia

Who this might be right for
Parkinson's DiseaseDyskinesia
EMD Serono 360
Testing effectiveness (Phase 2)UnknownNCT02347059
What this trial is testing

L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University of Toronto 40
Testing effectiveness (Phase 2)Study completedNCT00610103
What this trial is testing

Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy

Who this might be right for
Parkinson's Disease
Kyowa Kirin Co., Ltd. 16
Large-scale testing (Phase 3)Study completedNCT02601586
What this trial is testing

Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Toulouse 67
Early research (Phase 1)Study completedNCT03097211
What this trial is testing

Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg

Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 38
Large-scale testing (Phase 3)Study completedNCT00203164
What this trial is testing

Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Teva Branded Pharmaceutical Products R&D, Inc. 254
Testing effectiveness (Phase 2)Study completedNCT00239564
What this trial is testing

Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Impax Laboratories, LLC 12
Post-approval studies (Phase 4)Study completedNCT02513485
What this trial is testing

Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa

Who this might be right for
Depression
Emory University 57
Testing effectiveness (Phase 2)UnknownNCT03576638
What this trial is testing

Study to Assess Pharmacokinetics of Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Parkinson's Disease Patients

Who this might be right for
Parkinson Disease
Intec Pharma Ltd. 12
Not applicableStudy completedNCT01429207
What this trial is testing

Capturing Parkinson's Disease Medication Side Effects During Daily Activities

Who this might be right for
Parkinson's DiseaseDyskinesia
Great Lakes NeuroTechnologies Inc. 15
Large-scale testing (Phase 3)Study completedNCT00203034
What this trial is testing

Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

Who this might be right for
Parkinson's Disease
Teva Branded Pharmaceutical Products R&D, Inc. 472
Post-approval studies (Phase 4)Study completedNCT00888186
What this trial is testing

Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics

Who this might be right for
Parkinson DiseaseDyskinesias
Uppsala University 5
Testing effectiveness (Phase 2)Study completedNCT01491529
What this trial is testing

Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
DyskinesiasParkinson DiseaseMovement Disorders+2 more
Novartis Pharmaceuticals 154
Testing effectiveness (Phase 2)Study completedNCT01538329
What this trial is testing

Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Toulouse 210
Load More Results